The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases.

FGFR3 gene fusion NGS analysis NTRK gene fusion TMPRSS gene fusion brain metastases glioma

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2024
Historique:
received: 05 02 2024
accepted: 17 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

Oncogenic fusions of neurotrophic receptor tyrosine kinase 140 samples fixed and paraffin-embedded tissue (FFPE) of adult patients (59 of gliomas [17 of WHO grade II, 20 of WHO grade III and 22 glioblastomas] and 81 of brain metastasis (BM) of different primary tumors) are analyzed. Identification of We identified an This study provides data on the incidence of

Sections du résumé

Background UNASSIGNED
Oncogenic fusions of neurotrophic receptor tyrosine kinase
Methods UNASSIGNED
140 samples fixed and paraffin-embedded tissue (FFPE) of adult patients (59 of gliomas [17 of WHO grade II, 20 of WHO grade III and 22 glioblastomas] and 81 of brain metastasis (BM) of different primary tumors) are analyzed. Identification of
Results UNASSIGNED
We identified an
Conclusions UNASSIGNED
This study provides data on the incidence of

Identifiants

pubmed: 39087020
doi: 10.3389/fonc.2024.1382394
pmc: PMC11288828
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1382394

Informations de copyright

Copyright © 2024 Metellus, Camilla, Bialecki, Beaufils, Vellutini, Pellegrino, Tomasini, Ahluwalia, Mansouri, Nanni and Ouafik.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision

Auteurs

Philippe Metellus (P)

Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.
Ramsay Santé, Hôpital Privé Clairval, Département de Neurochirurgie, Marseille, France.

Clara Camilla (C)

Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.
Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

Emilie Bialecki (E)

Ramsay Santé, Hôpital Privé Clairval, Département de Neurochirurgie, Marseille, France.

Nathalie Beaufils (N)

Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

Christine Vellutini (C)

Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.

Eric Pellegrino (E)

Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

Pascale Tomasini (P)

Aix Marseille Univ, APHM, Oncologie multidisciplinaire et innovations thérapeutiques, Marseille, France.
Aix-Marseille Univ, Centre national de Recherche Scientifique (CNRS), Inserm, CRCM, Marseille, France.

Manmeet S Ahluwalia (MS)

Miami Cancer Institute, Baptist Health South Florida, Miami, FL, United States.
Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.

Alireza Mansouri (A)

Department of Neurosurgery, Penn State Cancer Institute, Hershey, PA, United States.

Isabelle Nanni (I)

Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

L'Houcine Ouafik (L)

Aix Marseille Univ, Centre national de Recherche Scientifique (CNRS), INP, Inst Neurophysiopathol, Marseille, France.
Aix Marseille Univ, APHM, CHU Timone, Service d'OncoBiologie, Marseille, France.

Classifications MeSH